Iovance Biotherapeutics, Inc. (IOVA)
3.445
-0.10
(-2.96%)
USD |
NASDAQ |
May 08, 10:04
Iovance Biotherapeutics Shareholders Equity (Quarterly) : 698.58M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Orthofix Medical, Inc. | 435.19M |
| InfuSystem Holdings, Inc. | 57.33M |
| Axogen, Inc. | 244.81M |
| Avanos Medical, Inc. | 782.10M |
| KalVista Pharmaceuticals, Inc. | -2.711M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 913.17M |
| Total Liabilities (Quarterly) | 214.59M |
| Debt to Equity Ratio | 0.0708 |
| Current Ratio | 3.200 |
| Net Debt Paydown Yield | 0.52% |